Literature DB >> 15128505

Characterization of humanized antibodies secreted by Aspergillus niger.

Michael Ward1, Cherry Lin, Doreen C Victoria, Bryan P Fox, Judith A Fox, David L Wong, Hendrik J Meerman, Jeff P Pucci, Robin B Fong, Meng H Heng, Naoya Tsurushita, Christine Gieswein, Minha Park, Huaming Wang.   

Abstract

Two different humanized immunoglobulin G1(kappa) antibodies and an Fab' fragment were produced by Aspergillus niger. The antibodies were secreted into the culture supernatant. Both light and heavy chains were initially synthesized as fusion proteins with native glucoamylase. After antibody assembly, cleavage by A. niger KexB protease allowed the release of free antibody. Purification by hydrophobic charge induction chromatography proved effective at removing any antibody to which glucoamylase remained attached. Glycosylation at N297 in the Fc region of the heavy chain was observed, but this site was unoccupied on approximately 50% of the heavy chains. The glycan was of the high-mannose type, with some galactose present, and the size ranged from Hex(6)GlcNAc(2) to Hex(15)GlcNAc(2). An aglycosyl mutant form of antibody was also produced. No significant difference between the glycosylated antibody produced by Aspergillus and that produced by mammalian cell cultures was observed in tests for affinity, avidity, pharmacokinetics, or antibody-dependent cellular cytotoxicity function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128505      PMCID: PMC404402          DOI: 10.1128/AEM.70.5.2567-2576.2004

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  33 in total

Review 1.  Recent advances in the large-scale production of antibody fragments using lower eukaryotic microorganisms.

Authors:  L G Frenken; J G Hessing; C A Van den Hondel; C T Verrips
Journal:  Res Immunol       Date:  1998 Jul-Aug

Review 2.  IgG-Fc-mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation.

Authors:  R Jefferis; J Lund; J D Pound
Journal:  Immunol Rev       Date:  1998-06       Impact factor: 12.988

Review 3.  Efficient production of secreted proteins by Aspergillus: progress, limitations and prospects.

Authors:  R J Gouka; P J Punt; C A van den Hondel
Journal:  Appl Microbiol Biotechnol       Date:  1997-01       Impact factor: 4.813

4.  High-level secretion of two antibody single chain Fv fragments by Pichia pastoris.

Authors:  P Eldin; M E Pauza; Y Hieda; G Lin; M P Murtaugh; P R Pentel; C A Pennell
Journal:  J Immunol Methods       Date:  1997-02-14       Impact factor: 2.303

5.  Multiple interactions of IgG with its core oligosaccharide can modulate recognition by complement and human Fc gamma receptor I and influence the synthesis of its oligosaccharide chains.

Authors:  J Lund; N Takahashi; J D Pound; M Goodall; R Jefferis
Journal:  J Immunol       Date:  1996-12-01       Impact factor: 5.422

6.  Humanization of an anti-p185HER2 antibody for human cancer therapy.

Authors:  P Carter; L Presta; C M Gorman; J B Ridgway; D Henner; W L Wong; A M Rowland; C Kotts; M E Carver; H M Shepard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

7.  Use of Aspergillus overproducing mutants, cured for integrated plasmid, to overproduce heterologous proteins.

Authors:  M Ward; L J Wilson; K H Kodama
Journal:  Appl Microbiol Biotechnol       Date:  1993-08       Impact factor: 4.813

8.  Abnormally short serum half-lives of IgG in beta 2-microglobulin-deficient mice.

Authors:  V Ghetie; J G Hubbard; J K Kim; M F Tsen; Y Lee; E S Ward
Journal:  Eur J Immunol       Date:  1996-03       Impact factor: 5.532

9.  High level Escherichia coli expression and production of a bivalent humanized antibody fragment.

Authors:  P Carter; R F Kelley; M L Rodrigues; B Snedecor; M Covarrubias; M D Velligan; W L Wong; A M Rowland; C E Kotts; M E Carver
Journal:  Biotechnology (N Y)       Date:  1992-02

10.  Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1.

Authors:  A Wright; S L Morrison
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more
  19 in total

Review 1.  Lepidopteran cells, an alternative for the production of recombinant antibodies?

Authors:  Martine Cérutti; Josée Golay
Journal:  MAbs       Date:  2012-04-26       Impact factor: 5.857

Review 2.  Cell culture processes for monoclonal antibody production.

Authors:  Feng Li; Natarajan Vijayasankaran; Amy Yijuan Shen; Robert Kiss; Ashraf Amanullah
Journal:  MAbs       Date:  2010-09-01       Impact factor: 5.857

3.  Extracellular Expression in Aspergillus niger of an Antibody Fused to Leishmania sp. Antigens.

Authors:  Denis Magaña-Ortíz; Francisco Fernández; Achim M Loske; Miguel A Gómez-Lim
Journal:  Curr Microbiol       Date:  2017-08-31       Impact factor: 2.188

4.  Extracellular production of neoculin, a sweet-tasting heterodimeric protein with taste-modifying activity, by Aspergillus oryzae.

Authors:  Ken-ichiro Nakajima; Tomiko Asakura; Jun-ichi Maruyama; Yuji Morita; Hideaki Oike; Akiko Shimizu-Ibuka; Takumi Misaka; Hiroyuki Sorimachi; Soichi Arai; Katsuhiko Kitamoto; Keiko Abe
Journal:  Appl Environ Microbiol       Date:  2006-05       Impact factor: 4.792

Review 5.  Glycoengineering of Antibodies for Modulating Functions.

Authors:  Lai-Xi Wang; Xin Tong; Chao Li; John P Giddens; Tiezheng Li
Journal:  Annu Rev Biochem       Date:  2019-03-27       Impact factor: 23.643

6.  Efficient antibody production upon suppression of O mannosylation in the yeast Ogataea minuta.

Authors:  Kousuke Kuroda; Kazuo Kobayashi; Yoshinori Kitagawa; Taishiro Nakagawa; Haruhiko Tsumura; Toshihiro Komeda; Daisuke Shinmi; Eiji Mori; Kazuhiro Motoki; Kazumi Fuju; Teruyuki Sakai; Koichi Nonaka; Takeshi Suzuki; Kimihisa Ichikawa; Yasunori Chiba; Yoshifumi Jigami
Journal:  Appl Environ Microbiol       Date:  2007-11-26       Impact factor: 4.792

7.  Generation, annotation, and analysis of an extensive Aspergillus niger EST collection.

Authors:  Natalia Semova; Reginald Storms; Tricia John; Pascale Gaudet; Peter Ulycznyj; Xiang Jia Min; Jian Sun; Greg Butler; Adrian Tsang
Journal:  BMC Microbiol       Date:  2006-02-02       Impact factor: 3.605

8.  Expression of human alpha1-proteinase inhibitor in Aspergillus niger.

Authors:  Elena Karnaukhova; Yakir Ophir; Loc Trinh; Nimish Dalal; Peter J Punt; Basil Golding; Joseph Shiloach
Journal:  Microb Cell Fact       Date:  2007-10-29       Impact factor: 5.328

9.  Ligation Independent Cloning of Polycistronic, Genetically Modified, HuMAb4D5-8 F (ab') 2, in Bacterial Plasmid.

Authors:  Leila Farahmand; Keivan Majidzadeh-A; Zargham Sepehrizadeh; Mohammad Reza Mofid; Rezvan Esmaeili; Mojtaba Tabatabaei Yazdi
Journal:  Avicenna J Med Biotechnol       Date:  2012-01

10.  Production, purification, and characterization of human alpha1 proteinase inhibitor from Aspergillus niger.

Authors:  Liat Chill; Loc Trinh; Parastoo Azadi; Mayumi Ishihara; Roberto Sonon; Elena Karnaukhova; Yakir Ophir; Basil Golding; Joseph Shiloach
Journal:  Biotechnol Bioeng       Date:  2009-02-15       Impact factor: 4.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.